Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Medplus Health Services's Enterprise Value is ₹172,540 Mil.
Medplus Health Services's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was ₹0 Mil. Therefore, Medplus Health Services's EV-to-FCF for today is .
The historical rank and industry rank for Medplus Health Services's EV-to-FCF or its related term are showing as below:
NSE:MEDPLUS'
s EV-to-FCF Range Over the Past 10 Years
Min: 0 Med: 0 Max: 48.32
Current: 48.32
During the past 8 years, the highest EV-to-FCF of Medplus Health Services was 48.32. The lowest was 0.00. And the median was 0.00.
NSE:MEDPLUS's EV-to-FCF is ranked worse than 83.21% of 405
companies
in the Healthcare Providers & Services industry
Industry Median: 18.23
vs NSE:MEDPLUS: 48.32
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medplus Health Services (NSE:MEDPLUS) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medplus Health Services's PE Ratio (TTM) for today is calculated as:
Medplus Health Services's share price for today is ₹690.30.
Medplus Health Services's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹17.520.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medplus Health Services EV-to-FCF Competitor Comparison
For the Pharmaceutical Retailers subindustry, Medplus Health Services's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medplus Health Services EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medplus Health Services's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Medplus Health Services's EV-to-FCF falls into.
Medplus Health Services's current Enterprise Value is ₹172,540 Mil.
Medplus Health Services's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Is Medplus Health Services (NSE:MEDPLUS) Overvalued in 2026?
Based on GuruFocus' analysis, Medplus Health Services stock appears to be undervalued.
The current stock price of ₹690.30 is trading 28.3% below its estimated GF Value™ of ₹962.53.
GuruFocus considers Medplus Health Services to be Modestly Undervalued.
Key valuation signals for NSE:MEDPLUS:
EV-to-FCF:
GF Value™: ₹962.53 vs. price of ₹690.30 (28.3% below fair value)
No single metric tells the full story. See the NSE:MEDPLUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medplus Health Services Ltd is a pharmacy retailer. It offers pharmaceutical and wellness products such as medicines, vitamins, medical devices, test kits, and others. The company also offers an omnichannel platform wherein customers can purchase products through stores, place orders over the telephone, online orders, and a Click and Pick facility. Its operating segments include Retail, Diagnostics, and Others.
76GF Score
Get the complete analysis for NSE:MEDPLUS
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MEDPLUS has been successfully added to your 
